Insider Transactions in Q2 2025 at Resmed Inc (RSMDF)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 08
2025
|
Brett Sandercock Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,000
-1.1%
|
$215,000
$215.58 P/Share
|
|
Apr 07
2025
|
Michael J. Farrell Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
8,009
-1.73%
|
$1,673,881
$209.85 P/Share
|
|
Apr 07
2025
|
Michael J. Farrell Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,009
+1.7%
|
$808,909
$101.64 P/Share
|
|
Apr 02
2025
|
Peter C Farrell Director |
SELL
Open market or private sale
|
Direct |
2,000
-2.66%
|
$438,000
$219.74 P/Share
|
|
Apr 01
2025
|
Michael J Rider Global General Counsel |
SELL
Open market or private sale
|
Direct |
64
-0.72%
|
$14,208
$222.86 P/Share
|